期刊文献+

荧光定量PCR法检测鼻咽癌血浆游离EBV DNA的临床意义 被引量:2

Clinical significance of Plasma Epstein-Bar virus DNA concentration in nasopharyngeal carcinoma with fluorescent quantitative PCR
下载PDF
导出
摘要 目的通过检测血浆中游离EBVDNA水平,探讨其在鼻咽癌诊断、鉴别诊断、临床分期中的临床意义。方法采用荧光定量PCR方法定量检测111例初治鼻咽癌患者和107例放疗后持续缓解患者血浆游离EBVDNA水平。结果初治组及临床缓解组血浆中游离EBVDNA检出率分别为74.8%(83/111)和4.6%(5/107),初治组检出率显著高于临床缓解组,在统计学上有显著性差异;初治组中晚期(Ⅲ+Ⅳ期)血浆游离EBVDNA拷贝数显著高于早期(Ⅰ+Ⅱ期);N晚期(N2+N3)拷贝数显著高于早期(N0+N1);T晚期(T3+T4)拷贝数显著高于早期(T1+T2);统计学上均有显著性差异。结论荧光定量PCR方法检测血浆中游离EBVDNA是一种敏感可靠的方法,血浆游离EBVDNA定量检测对鼻咽癌诊断、鉴别诊断、分期、治疗后监测有重要的临床意义,有望成为鼻咽癌肿瘤学标记物。 Objective To study the clinical significance of plasma EBV DNA concentration in diagnosis.differential diagnosis,clinical staging in nasopharyngeal carcinoma.Methods Using fluorescent quantitative PCR.the level of plasma EBV DNA were detected in 111 patients with primary NPC and 107 patients with, cliaical remission after radiotberapy.Results Plasma EBV DNA was detectable in 74.8%(83/111 )of primary NPC and 4.6%(5/107)of clinical remission parle,Its. there was a significant difference statistically in the detectable proportion betwee,1 the two groups. In primary NPC .patients in advanced TNM stage had signifieantly higher plasma EBV DNA level than those of in early TNM stage.Conclusion Fluorescent quantitative PCR in detecting EBV DNA is a sensitive.reliable method,the quantification of plasma EBV DNA is of sifnificance in diagnosis,differential diagnosis.clinical staging and monitoring after treatment.It is possible that plasma EBV DNA should become a serologic marker of NPC.
出处 《江西医药》 CAS 2005年第12期801-802,共2页 Jiangxi Medical Journal
关键词 鼻咽癌 荧光定量PCR EBV DNA nasopharyngeal carcinoma fluorescent quantitative PCR EBV DNA
  • 相关文献

参考文献7

二级参考文献33

  • 1刘泰福,徐国镇.全国鼻咽癌会议纪要[J].中华放射肿瘤学杂志,1992,0(4):5-10. 被引量:132
  • 2刘振声,李宝民,刘彦仿,王锦玲,Irene,曾毅.头颈肿瘤组织中Epstein-Barr病毒编码的RNAs原位杂交检测[J].中华实验和临床病毒学杂志,1996,10(2):163-165. 被引量:3
  • 3[1]Fandi A, Altun M, Azli N, et al . Nasopharyngeal cancer : epidemiology,staging,and treatment [J ]. Semin Oncol , 1994, 21:382-397.
  • 4[2]Liebowitz D. Nasopharyngeal carcinoma : the Epstein -Barr virus association [J ]. Semin Oncol , 1994, 21: 376- 381.
  • 5[3]Min H, Hong M, Ma J, et al . A new staging system for nasopharyngeal carcinoma in China [J ]. Int J Radiat Oncol Biol Phys , 1994, 30: 1037- 1042.
  • 6[4]Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985:overall survival and patterns of failure [J]. Int J Radiat Oncol Biol Phys,1992, 23:261- 270.
  • 7[5]Chen XQ,Stroun M,Magnenat JL,et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients [J]. Nat Med,1996,2:1033- 1035.
  • 8[6]Nawroz H, Koch W, Anker P, et al. Microsatellite alterations in serum DNA of head and neck cancer patients [J].Nat Med,1996,2:1035- 1037.
  • 9[7]Anker P, Mulcahy H, Chen XQ, et al . Detection of circulating tumor DNA in the blood (plasma /serum )of cancer patients [J] . Cancer Metastasis Rev ,1999,18: 65- 73.
  • 10[8]Mutirangura A, Pornthanakasem W, Theamboonlers A, et al. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma [J]. Clin Cancer Res,1998,4:665- 669.

共引文献64

同被引文献25

引证文献2

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部